In this study, we hypothesize that multiple TMPRSS2:ERG fusion subtypes and additional low-prevalent TMPRSS2:ETS fusion genes are collectively more informative than any single marker alone in the noninvasive detection and stratification of clinically significant prostate cancer. This evidence concerns the gene TMPRSS2 and prostate carcinoma.